semaglutide cardiovascular US FDA approves weight loss drug Wegovy to prevent events Semaglutide cardiovascular outcomes align more

Step 2: Track protein intake for one week

A carefully evaluates whether lower-dose metabolic support or more adjusted protocols are appropriate based on each patients goals, health history, tolerance, and response

Jco 39 (12), 13831388

Reference: Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study by Heidi Taipale, Mark Taylor, Markku Lhteenvuo, Ellenor Mittendorfer-Rutz, Antti Tanskanen and Jari Tiihonen, April 2026, The Lancet Psychiatry

Employers and TPS recipients should review EAD expiration dates, monitor ongoing developments, and ensure compliance with Form I-9 and E-Verify requirements